Clinical Trials Directory

Trials / Completed

CompletedNCT04206163

Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis

Somatostatin Receptor Imaging in Inflammatory Heart Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Vastra Gotaland Region · Other Government
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This prospective imaging study investigates the diagnostic ability of Gallium-68 DOTA-TOC (68Ga-DOTA-TOC) positron emission tomography/computed tomography (PET/CT) in the clinical work-up of patients with 1) clinically suspected acute myocarditis (n=30-40) and 2) clinically suspected cardiac sarcoidosis (n=30-40) using clinical diagnostic criteria as well as endomyocardial biopsy as reference. Furthermore, 68Ga-DOTA-TOC PET/CT findings will be compared with results from contrast-enhanced magnetic resonance imaging (MRI) and in case of cardiac sarcoidosis even Fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT, which are both performed as part of the clinical routine work-up.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST68Ga-DOTA-TOC PET/CTSomatostatin receptor imaging
BIOLOGICALBlood sampleAnalysis of inflammatory biomarkers

Timeline

Start date
2020-01-20
Primary completion
2024-06-24
Completion
2024-06-24
First posted
2019-12-20
Last updated
2024-09-27

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04206163. Inclusion in this directory is not an endorsement.